Best Paper Award
Dear Colleagues,
We are pleased to announce the winners of the Cancers 2021 Best Paper Award. All papers published from 1 January 2021 to 31 December 2021 in Cancers were considered for the award. After a thorough evaluation of the originality and significance of the papers, citations, and downloads, four winners were selected.
Two Reviews:
PD-L1, TMB, MSI, and Other Predictors of Response to Immune Checkpoint Inhibitors in Biliary Tract Cancer
By Alessandro Rizzo et al.
Cancers 2021, 13(3), 558; doi: 10.3390/cancers13030558
STING Agonists as Cancer Therapeutics
By Afsaneh Amouzegar and Jason J. Luke et al.
Cancers 2021, 13(11), 2695; doi: 10.3390/cancers13112695
Two Articles:
LAG-3 Blockade with Relatlimab (BMS-986016) Restores Anti-Leukemic Responses in Chronic Lymphocytic Leukemia
By Christian Sordo-Bahamonde, Ana P. González-Rodríguez and Segundo Gonzalez et al.
Cancers 2021, 13(9), 2112; doi: 10.3390/cancers13092112
The Role of the Immune Metabolic Prognostic Index in Patients with Non-Small Cell Lung Cancer (NSCLC) in Radiological Progression during Treatment with Nivolumab
By Matteo Bauckneht et al.
Cancers 2021, 13(13), 3117; doi: 10.3390/cancers13133117
Each winner will receive CHF 500 and a chance to publish a paper free of charge in Cancers in 2023 after peer review.
Please join us in congratulating the winners of the Cancers 2021 Best Paper Award. We would also like to take this opportunity to thank all of our authors for your continued support of Cancers.
Kind regards,
Cancers Editorial Office
Eligibility and Requirements
– All papers published in Cancers will be eligible (Both regular and Special Issue submissions).Winner
Winner